Probiotix Health Aktie
Marktkapitalisierung
17,36 Mio. €
17,36 Mio. €
Streubesitz
65,57%
KGV
-
Index-Zuordnung
-
PROBIOTIX HEALTH LS-05 Unternehmensprofil
ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 2022. The company was incorporated in 2021 and is based in Wakefield, the United Kingdom. ProBiotix Health Plc is a subsidiary of OptiBiotix Health Plc.
Vorstand
Herr Steen Dannemann Andersen
CEO & Geschäftsführender Direktor
Herr Cellan Davies
Leiterin Marketing
Herr Mark Kingsley Collingbourne
Sekretärin
Aktionärsstruktur
73,633%
Freefloat
68,635%
Individuelle Aktionäre
4,998%
Institutionelle Aktionäre
Termine
Stammdaten
| Nennwert/Aktie | - |
| Land | Deutschland |
| Währung | EUR |
| Branche | Biotechnologie |
| Aktientyp | - |
| Sektor | Gesundheit |
| Gattung | - |
Quelle: Leeway